Bull&Bear | G1 Therapeutics Surges 66% After Acquisition, Nevro Drops 44% on Downgrade

Top Performing Stocks:

G1 Therapeutics (GTHX) surged 66.12%, marking a two-day increase of 78.73%. G1 Therapeutics was acquired by Pharmacosmos.

PetIQ (PETQ) rose by 47.89%. PetIQ agreed to a $1.5 billion privatization deal with the Bancroft Group.

Latham Group (SWIM) increased by 41.48%. Baird maintained an "outperform" rating on Latham Group and raised the price target to $5.50.

Upstart (UPST) climbed 39.51%, posting a three-day gain of 40.15%. The fintech lending company Upstart Holdings saw its stock rise by 38% following its second-quarter earnings report.

Inogen (INGN) rose by 35.95%. Inogen's second-quarter earnings exceeded expectations, leading to a significant pre-market gain in its stock price.

Poor Performing Stocks:

Nevro (NVRO) plummeted by 44.42%. Nevro's stock dropped sharply due to a downgrade in ratings following revised guidance.

Emergent (EBS) declined by 41.99%. Emergent BioSolutions reported a second-quarter loss that exceeded expectations, resulting in a 38.4% drop in stock price.

Office Depot (ODP) fell by 35.25%, continuing a five-day decline of 41.87%. The parent company of Office Depot, ODP, cut its FY24 guidance due to a 10% decrease in sales.

Porch Group (PRCH) decreased by 32.37%. Shares of Porch Group fell after the company reported Q2 financial results that were below expectations and lowered its FY24 guidance.

Additional Financial Details:

High Course Group reported second-quarter operating income of $131.7 million, compared to the Street's estimate of $136.5 million.